PHILADELPHIA, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Kaskela Law LLC is investigating Eidos Therapeutics, Inc. (“Eidos”) (EIDX) on behalf of the company’s shareholders.
The investigation seeks to determine whether Eidos and/or the company’s officers and directors have violated the securities laws, and whether Eidos shareholders have been harmed as a result of such actions.
Eidos shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585 or (888) 715 – 1740, or by email at firstname.lastname@example.org, to discuss this investigation and their legal rights and options. Additional information may also be found at http://kaskelalaw.com/case/eidos-thera/.
Kaskela Law LLC exclusively represents investors in securities, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.